Unlock instant, AI-driven research and patent intelligence for your innovation.

Apabetalone crystal form and preparation method thereof

A crystal form and crystal technology, which is applied in the field of pharmaceutical crystallization, can solve the problems of affecting drug absorption, not suitable for large-scale industrial production, and slow gas phase diffusion, so as to achieve good solid solubility and improve bioavailability.

Active Publication Date: 2019-05-31
SHENZHEN JINGTAI TECH CO LTD +1
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

CS4 needs to be obtained by heating CS11, the heating temperature is high (200-220°C), the energy consumption is large, and the economic benefit is low, so it is not suitable for development
CS7 is obtained by gas phase diffusion. Due to the slow gas phase diffusion rate, the process of crystallization is slow, which is not suitable for large-scale industrial production. Similarly, the crystal forms CS9, CS13 and CS20 prepared by slow volatilization at room temperature are limited by the evaporation rate. It is not conducive to large-scale industrial production
Crystal forms CS13, CS8 and CS1 have low solubility, which affects the absorption of drugs in the human body
Although CS2 and CS11 have high solubility, they have high hygroscopicity and poor stability, which is not conducive to long-term storage of drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Apabetalone crystal form and preparation method thereof
  • Apabetalone crystal form and preparation method thereof
  • Apabetalone crystal form and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Put 0.06g of Apabetalone raw material in a mixed solvent of 2ml of water and 1,4-dioxane (each 1ml of water and 1,4-dioxane), stir at 30°C for suspension crystallization, filter after 48h, White crystals were obtained and dried at 25°C for 12 hours to obtain the 1,4-dioxane solvent compound of Apabetalone. Take 0.03 g of the obtained 1,4-dioxane solvate solid and heat it in a vacuum drying oven at a heating temperature of 130° C. for 10 minutes to obtain white crystals, namely the crystal form A. The powder X-ray diffraction spectrum of crystal form A product shows that there are characteristic peaks at 7.2, 9.9, 12.6, 13.3, 14.4, 16.9, 19.8, 21.8, 24.1 degrees with diffraction angle 2θ, and figure 1 Consistent, the DSC spectrum has characteristic endothermic peaks at 217, 218 and 232°C respectively, which is consistent with image 3 Consistent, confirm that the obtained product is the Apabetalone crystal form A crystal. The obtained crystal has high crystallinity and...

Embodiment 2

[0038]Put 0.08g of Apabetalone raw material in a mixed solvent of 2ml of water and 1,4-dioxane (each 1ml of water and 1,4-dioxane), stir at 40°C for suspension crystallization, filter after 36h, White crystals were obtained, which were dried at 40°C for 6 hours to obtain the 1,4-dioxane solvent compound of Apabetalone. Take 0.03 g of the obtained 1,4-dioxane solvate solid and heat it in a vacuum drying oven at a heating temperature of 150° C. for 10 minutes to obtain white crystals, namely the crystal form A. The powder X-ray diffraction spectrum of crystal form A product shows that there are characteristic peaks at 7.1, 9.8, 12.5, 13.2, 14.3, 16.8, 19.7, 21.7, 24.0 degrees with diffraction angle 2θ, and figure 1 Consistent, the DSC spectrum has characteristic endothermic peaks at 217, 218 and 232°C respectively, which is consistent with image 3 Consistent, confirm that the obtained product is the Apabetalone crystal form A crystal. The obtained crystal has high crystallini...

Embodiment 3

[0040] Put 0.1g of Apabetalone raw material in a mixed solvent of 2ml of water and 1,4-dioxane (each 1ml of water and 1,4-dioxane), stir at 50°C for suspension crystallization, filter after 24h, White crystals were obtained and dried at 25°C for 24 hours to obtain the 1,4-dioxane solvent compound of Apabetalone. Take 0.03 g of the obtained 1,4-dioxane solvate solid and heat it in a vacuum drying oven at a heating temperature of 130° C. for 30 minutes to obtain white crystals, namely the crystal form A. The powder X-ray diffraction spectrum of crystal form A product shows that there are characteristic peaks at 7.0, 9.7, 12.3, 13.0, 14.1, 16.6, 19.5, 21.5, 23.8 degrees with diffraction angle 2θ, and figure 1 Consistent, the DSC spectrum has characteristic endothermic peaks at 217, 218 and 232°C respectively, which is consistent with image 3 Consistent, confirm that the obtained product is the Apabetalone crystal form A crystal. The obtained crystal has high crystallinity and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
solubility (mass)aaaaaaaaaa
Login to View More

Abstract

The invention provides an Apabetalone crystal form and a preparation method thereof. The characteristic peaks represented by diffraction angle 2[theta] of the crystal form are: 7.2+ / -0.2, 9.9+ / -0.2, 12.6+ / -0.2, 13.3+ / -0.2, 14.4+ / -0.2, 16.9+ / -0.2, 19.8+ / -0.2, 21.8+ / -0.2, and 24.1+ / -0.2. The Apabetalone crystal form is evenly paved on an opened culture dish, then the culture dish is sealed and placed in a drier; the temperature is controlled at 40 DEG C, the humidity is controlled at 75%RH, an accelerated stability test is carried out; the crystal form is sampled and detected by XRD in 5th and 10th days, the XRD results are compared with the XRD result in the first day; the comparison results show that the Apabetalone crystal form is not changed, the product stability is good, and the crystal form is easy to store. The crystal form is convenient for the processing, storage, and transportation of medical preparations, and the storage and transportation cost is saved.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical crystallization, in particular to a 2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxyquinazoline-4 (3H)-keto (Apabetalone) crystal form and preparation method thereof. Background technique [0002] Apabetalone is a bromodomain protein inhibitor (US8053440B2) developed by Resverlogix in Canada, which is mainly used for the treatment of cardiovascular diseases, type 2 diabetes, coronary heart disease, atherosclerosis and other diseases. According to statistics, cardiovascular disease is one of the most serious diseases threatening human life in the world today, with high morbidity and mortality. However, the current drugs for the treatment of cardiovascular diseases cannot meet people's needs, and new drugs need to be continuously developed. The new drug Apabetalone can inhibit the BRD4 (full name bromodomain-containing protein 4, bromodomain protein 4) region in the BET family, ther...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D239/91
Inventor 龚俊波刘裕黄嘉骏吴送姑张旭侯宝红汤伟伟尹秋响
Owner SHENZHEN JINGTAI TECH CO LTD